Gene hunt: 10,000 cancer patients to get personalized drug matches

NCT ID NCT02534649

First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 28 times

Summary

This study aims to find specific genetic changes in the tumors of 10,000 adults with advanced solid or blood cancers. By analyzing tumor DNA and immune markers, researchers hope to match each patient with a targeted drug or clinical trial that may work best for their unique cancer. The goal is to improve treatment outcomes by personalizing therapy based on each tumor's molecular profile.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Centre Eugène Marquis

    ACTIVE_NOT_RECRUITING

    Rennes, France

  • Centre Hospitalier de Pau

    NOT_YET_RECRUITING

    Pau, 64000, France

    Contact

  • Centre Hospitalier de la Côte Basque

    RECRUITING

    Bayonne, 64000, France

    Contact

  • Clinique Marzet

    RECRUITING

    Pau, 64000, France

    Contact

  • Clinique Tivoli-Ducos

    RECRUITING

    Bordeaux, 33000, France

    Contact Email: •••••@•••••

    Contact

  • Institut Bergonie

    RECRUITING

    Bordeaux, 33076, France

    Contact

  • Polyclinique Bordeaux Nord Aquitaine

    RECRUITING

    Bordeaux, 33077, France

    Contact

Conditions

Explore the condition pages connected to this study.